EternoGen Aesthetics, LLC developer and manufacturer of advanced collagen scaffolds, announces the successful completion of its financial round. It has secured $5MM to prepare for the 2016 European commercialization of Rapid Polymerizing Collagen (RPC Pure-Collagen), the first of a rich pipeline of products delivering natural results through Bio-Dermal Restoration in facial aesthetics.
This financing enables RPC Pure-Collagen to complete the European regulatory process. It also provides EternoGen Aesthetics with a strong foundation from which to expand RPC Pure-Collagen production and build a premium brand to create transformative change in the $3B (CAGR12%) global facial injectable market.
The parent Company EternoGen, LLC was founded in 2009 by an award winning academic research group from the University of Missouri, led by Professor Sheila Grant, a world authority in biomaterials. EternoGen has been a resident client at the MU Life Science Business Incubator since 2012.
